PHQ-9
Published research on PHQ-9.

A 2026 ANTLER mechanistic analysis found no evidence that maintaining antidepressants preserved a happier facial-emotion recognition pattern compared with placebo substitution at 12 weeks (a…
Read article →
A 147-person feasibility randomized trial found that both a structured AI therapy chatbot and general ChatGPT reduced PHQ-9 depression scores compared with assessment-only control, with effe…
Read article →
A 2026 NHANES analysis of 6,502 adults found that urinary 3-PBA, a pyrethroid insecticide metabolite, was modestly associated with depression risk at OR = 1.02 per 1 μg/L, while self-reporte…
Read article →
A 2026 NHANES mortality analysis found that adults with PHQ-9 depressive symptoms had lower long-term all-cause mortality when their CALLY index was higher: in the fully adjusted model, each…
Read article →
A 2026 participatory-design and case-study paper turned smartphone mental-health data into 6 clinician-facing visualizations for an 8-week anxiety/depression digital clinic, using feedback f…
Read article →
A 12-week randomized pilot trial in 60 Veterans with depression and psychiatric polypharmacy found that 30% had an actionable antidepressant gene-drug interaction, but immediate access to ph…
Read article →
A 2026 nationwide Korean analysis found that resistance exercise was associated with lower depression and anxiety scores after propensity score matching, while aerobic exercise alone was not…
Read article →